What is Global Immunocell Therapy Market?
The Global Immunocell Therapy Market is a rapidly expanding field in the healthcare sector. It involves the use of immune cells, such as T cells and natural killer cells, to treat various diseases, including cancer. The therapy works by enhancing the body's immune system to fight against diseases more effectively. The market for this innovative treatment has been growing steadily due to the increasing prevalence of chronic diseases and the need for more effective treatments. The therapy is also gaining popularity due to its potential to provide personalized treatment options based on the patient's unique immune response. The market is further driven by advancements in biotechnology and the growing investment in research and development activities. However, the high cost of therapy and the lack of awareness about its benefits may hinder the market growth. Despite these challenges, the market is expected to witness significant growth in the coming years due to the increasing demand for effective and personalized treatments.
Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy, Others in the Global Immunocell Therapy Market:
The Global Immunocell Therapy Market is segmented into Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy, and others. CAR T Cell Therapy is a type of immunotherapy that uses genetically engineered T cells to target and kill cancer cells. The therapy has shown promising results in treating various types of cancers, including leukemia and lymphoma. On the other hand, NK Cell Therapy uses natural killer cells, a type of white blood cell, to kill cancer cells. The therapy is being studied for its potential to treat various types of cancers, including lung, breast, and ovarian cancer. The other segment includes therapies that use other types of immune cells, such as dendritic cells and macrophages. These therapies are still in the early stages of development but have shown potential in preclinical and early clinical trials. The market for these therapies is expected to grow significantly in the coming years due to the increasing prevalence of cancer and the need for more effective treatments.
Hospitals, Clinics, Others in the Global Immunocell Therapy Market:
The Global Immunocell Therapy Market is widely used in hospitals, clinics, and other healthcare facilities. In hospitals, the therapy is used to treat patients with severe and life-threatening diseases, such as cancer. The therapy is administered under the supervision of experienced healthcare professionals to ensure its safety and effectiveness. In clinics, the therapy is used to treat patients with less severe diseases or those who are in the early stages of the disease. The therapy is also used in other healthcare facilities, such as research institutions, for clinical trials and research purposes. The use of the therapy in these facilities is expected to increase in the coming years due to the growing awareness about its benefits and the increasing investment in research and development activities.
Global Immunocell Therapy Market Outlook:
The Global Immunocell Therapy Market is expected to witness significant growth in the coming years. In 2023, the market was valued at US$ 1876 million and is anticipated to reach US$ 4413.7 million by 2030, witnessing a CAGR of 13.0% during the forecast period 2024-2030. This growth is higher than the global pharmaceutical market, which is expected to grow at a CAGR of 5% during the next six years. The chemical drug market, on the other hand, is estimated to increase from 1005 billion in 2018 to 1094 billion U. S. dollars in 2022. The growth of the Immunocell Therapy Market can be attributed to the increasing prevalence of chronic diseases and the need for more effective treatments. The market is also driven by advancements in biotechnology and the growing investment in research and development activities. However, the high cost of therapy and the lack of awareness about its benefits may hinder the market growth. Despite these challenges, the market is expected to witness significant growth in the coming years due to the increasing demand for effective and personalized treatments.
| Report Metric | Details |
| Report Name | Immunocell Therapy Market |
| Accounted market size in 2023 | US$ 1876 million |
| Forecasted market size in 2030 | US$ 4413.7 million |
| CAGR | 13.0% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline), Sorrento Therapeutics(Pipeline), Mustang Bio(Pipeline), Bluebird Bio(Pipeline), Cellectis(Pipeline), Allogene Therapeutics(Pipeline), Celyad(Pipeline) |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
